logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Sarepta Pharmaceuticals Jumps on Competitor’s Failure

  +Follow August 16, 2013 9:54AM
Share:
Tickers Mentioned:

Sarepta Therapeutics Inc. (SRPT) experienced a bit of schadenfreude on Aug. 16 as a direct competitor stumbled badly at the finish line.

Competitor GlaxoSmithKline plc (GSK) had been neck-and-neck with Serepta in the race to develop a breakthrough muscle disorder drug to treat Duchenne Muscular Dystrophy. Both drugs were far ahead of the pack in the development process.

That is, until Baird analyst Brian Skorney reported that Glaxo’s drug, drisapersen, has encountered major stumbling blocks on several fronts that could significantly hamper development. Skorney cited clinical, regulatory, and commercials issues with the drug. Most importantly, the drug did not seem to effectively treat symptoms of the disease at the targeted dose.

Serepta’s drug, eteplirsen, so far has seemed to be effective at treating symptoms of Duchenne. Clinical trials have taken place in the UK. On Aug. 7 the company released promising clinical trial information, which will form the basis of their application for US FDA approval in early 2014.

Duchenne is a severely debilitating form of muscular dystrophy. The recessive muscular degenerative disorder affects approximately 1 in 3,600 boys, and life expectancy for sufferers is usually around 25. A drug from either company would be the first on the American market designed to treat the disorder.

The London-based GlaxoSmithKline , which is the fourth largest pharmaceutical company in the world, shrugged off the setback. Their stock is up .33 percent to hit $51.70 a share.

Serepta is up 6.77 percent to hit $34.21 a share.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for GSK
Stock Signaling
21 Sep 14 23:01:20
Movers and Shakers: Trading on Major News: $EMC $PG $SAP $DRC $CNQR $GSK $AIG $JBLU $VVUS $PWE $CAG $STLD $PIR $WFC $ENDP #investors #dow
crhz1978
21 Sep 14 19:37:25
Here comes the $slv #silver capitulation rally. Way oversold- manipulation. #iPhone6 $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl
crhz1978
21 Sep 14 19:11:06
Here comes the $slv #silver spike!! ⤴️ #iPhone6 $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl
crhz1978
21 Sep 14 19:05:14
#us likely to send ground troops to fight #isis #iPhone6 $SlV $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl
crhz1978
21 Sep 14 18:31:15
SEC to investigate #silver manipulation ???happening. #iPhone6 $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl
crhz1978
21 Sep 14 18:12:57
@federalreserve @sec please investigate $slv #silver manipulation happening. #iPhone6 $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl
crhz1978
21 Sep 14 18:11:00
@federalreserve - please investigate $slv #silver manipulation happening. #iPhone6 $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl
crhz1978
21 Sep 14 18:08:11
$slv #silver being totally manipulated. Should be illegal. #iPhone6 $BABA $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $gld #JanetYellen
12Stocks.com Biotech
21 Sep 14 17:57:16
Glaxo’s China Fine Signals No Immunity for Multinationals.. http://t.co/MCOkGrsyGV $GSK #biotech #stocks
Stockaholics
21 Sep 14 15:39:01
$ELRA closed up 288.89% on over 315 MILLION Volume! Get our new penny stock picks: http://t.co/qloC4OFNEn $LFAP $GSK $ROX
Dan
21 Sep 14 15:14:43
$GSK high open interest range is 47.00 to 47.00 for option expiration 09/20/2014. http://t.co/0LsC0m38mm
Dan
21 Sep 14 15:01:59
$GSK Max Pain = 47.00. Maturity = 09/20/2014. Previous close = 47.38. http://t.co/ajvcjFOPGq
Lis!
21 Sep 14 14:50:48
RT @Bidnessetc: GSK has started a second phase of human trials for its Ebola vaccine in UK - http://t.co/5aXj0HCajP $GSK
TylerSoliday
21 Sep 14 12:46:19
$GSK http://t.co/m4tHTAajZB
ClickMediaUK
21 Sep 14 11:21:27
RT @StockSignaling: Movers and Shakers: Trading on Major News: $PG $SAP $DRC $CNQR $GSK $AIG $JBLU $VVUS $PWE $CAG $STLD $PIR $WFC $ENDP $U…
Auto Binary option
21 Sep 14 11:08:56
RT @1nvestor: 2/2: $GSK Daily chart with a Declining Trend-line http://t.co/nRv2CMqAQU
Auto Binary option
21 Sep 14 11:08:56
RT @1nvestor: 1/2: which chart do you like best? $GSK PnF http://t.co/V7JSgMcCDj
Derald Muniz
21 Sep 14 11:05:39
$GSK pays a 5.3% divvy
Derald Muniz
21 Sep 14 11:04:54
2/2: $GSK Daily chart with a Declining Trend-line http://t.co/nRv2CMqAQU
Derald Muniz
21 Sep 14 11:04:28
1/2: which chart do you like best? $GSK PnF http://t.co/V7JSgMcCDj
Stock Signaling
21 Sep 14 11:01:22
Movers and Shakers: Trading on Major News: $PG $SAP $DRC $CNQR $GSK $AIG $JBLU $VVUS $PWE $CAG $STLD $PIR $WFC $ENDP $UPS #analytics #mkt
awolam
21 Sep 14 04:16:59
RT @SeekingAlpha: Week In Review: GSK Ends China Bribery Investigation By Paying $489 Million Fine http://t.co/vDxGy5lTe4 $GSK $CASI $SPPI …
Evener Investment
21 Sep 14 04:15:39
RT @SeekingAlpha: Week In Review: GSK Ends China Bribery Investigation By Paying $489 Million Fine http://t.co/vDxGy5lTe4 $GSK $CASI $SPPI …
Seeking Alpha
21 Sep 14 04:11:05
Week In Review: GSK Ends China Bribery Investigation By Paying $489 Million Fine http://t.co/vDxGy5lTe4 $GSK $CASI $SPPI $LLY $MLSS
Stockaholics
21 Sep 14 02:10:45
$ELRA closed up 288.89% on over 315 MILLION Volume! Get our new penny stock picks: http://t.co/qloC4OFNEn $LFAP $GSK $ROX
TalkMarkets
20 Sep 14 23:30:01
Global Roundup: Stocks And Funds Making News At Week's End $GSK $TCEHY $BABA $VIVHY $NVO $LLY $BNS $CSIQ $VR http://t.co/US2HZEQSEo
Stock Signaling
20 Sep 14 23:01:22
Movers and Shakers: Trading on Major News: $PG $SAP $DRC $CNQR $GSK $AIG $JBLU $VVUS $PWE $CAG $STLD $PIR $WFC $ENDP $UPS #analyst #trading
Anthony
20 Sep 14 18:24:45
RT @WallStJesus: Somebody long term bullish $CLVS » RT @BiotechMoney18: $CLVS $OMED $JNJ $AZN $ECYT $GSK bios to watch next wk #ESMO14 http…
Toad
20 Sep 14 17:36:39
RT @BiotechMoney18: $CLVS $OMED $JNJ $AZN $ECYT $GSK some bios play to watch next week for #ESMO14
Al Sabogal
20 Sep 14 17:11:26
RT @WallStJesus: Somebody long term bullish $CLVS » RT @BiotechMoney18: $CLVS $OMED $JNJ $AZN $ECYT $GSK bios to watch next wk #ESMO14 http…
Sleek Money
20 Sep 14 16:55:51
$500 Million Fine Levied Against GlaxoSmithKline $GSK http://t.co/uUm5IAmaZ4
JE$US
20 Sep 14 12:08:39
Somebody long term bullish $CLVS » RT @BiotechMoney18: $CLVS $OMED $JNJ $AZN $ECYT $GSK bios to watch next wk #ESMO14 http://t.co/JuTQqK0yAB
kenr0966
20 Sep 14 11:54:11
RT @BiotechMoney18: $CLVS $OMED $JNJ $AZN $ECYT $GSK some bios play to watch next week for #ESMO14
$$$ Money $$$
20 Sep 14 11:39:55
$CLVS $OMED $JNJ $AZN $ECYT $GSK some bios play to watch next week for #ESMO14
Jon Marathon
20 Sep 14 11:10:24
RT @pharmalot: An FDA 'Revolving Door' fosters conflicts of interest on advisory panels.. details here http://t.co/7mhPj9B06k #pharma #FDA …
$$$ Money $$$
20 Sep 14 11:04:02
$GSK $TKMR $LAKE $BCRX $INO vaccines & ebola play.
Stock Signaling
20 Sep 14 11:01:30
Movers and Shakers: Trading on Major News: $PG $SAP $DRC $CNQR $GSK $AIG $JBLU $VVUS $PWE $CAG $STLD $PIR $WFC $ENDP $UPS #daytrader #mkt
Rajkumar Gupta
20 Sep 14 09:39:06
RT @FiercePharma: 10 volunteers receive Glaxo Ebola vaccine with no adverse effects yet http://t.co/kwgLjGrzT7 $GSK #pharma #vaccines by @E…
中津川亮
20 Sep 14 07:11:25
RT @biosimilarz: Another perspective on the $GSK bribery scandal in China from the UK Times newspaper, CC: @BioPharmaJosh http://t.co/r7uxU…
Thamara Mangue
20 Sep 14 05:45:52
RT @biosimilarz: Another perspective on the $GSK bribery scandal in China from the UK Times newspaper, CC: @BioPharmaJosh http://t.co/r7uxU…
Josh Berlin
20 Sep 14 05:34:40
RT @biosimilarz: Another perspective on the $GSK bribery scandal in China from the UK Times newspaper, CC: @BioPharmaJosh http://t.co/r7uxU…
12Stocks.com Biotech
20 Sep 14 05:32:04
[$$] GlaxoSmithKline Found Guilty of Bribery in China.. http://t.co/mXkny04q73 $GSK #biotech #stocks
Jose Bouza
20 Sep 14 04:26:49
RT @ScripDonnaDC: ICYMI: Lilly's Trulicity OK'd; can it top GLP-1 market? http://t.co/by2FzPpWKn $LLY #Trulicity #diabetes #pharma #biot…
Rectitude Market
20 Sep 14 03:09:24
RT @Sentifi_UK: China Fines #GlaxoSmithKline Nearly $500 Million in Bribery Case http://t.co/bEO2kFxH8x $GSK +3930% mentioned in News, Blog…
Biosimilarz
20 Sep 14 01:18:52
Another perspective on the $GSK bribery scandal in China from the UK Times newspaper, CC: @BioPharmaJosh http://t.co/r7uxUPpQYR
Stockaholics
20 Sep 14 00:36:53
$ELRA closed up 288.89% on over 315 MILLION Volume! Get our new penny stock picks: http://t.co/qloC4OFNEn $LFAP $GSK $ROX
Stock Signaling
19 Sep 14 23:01:25
Movers and Shakers: Trading on Major News: $PG $SAP $DRC $CNQR $GSK $AIG $JBLU $VVUS $PWE $CAG $STLD $PIR $WFC $ENDP $UPS #markets #nasdaq
Sentifi CH Market
19 Sep 14 22:29:49
RT @Sentifi_UK: China Fines #GlaxoSmithKline Nearly $500 Million in Bribery Case http://t.co/bEO2kFxH8x $GSK +3930% mentioned in News, Blog…
Sentifi UK_Market
19 Sep 14 22:02:46
China Fines #GlaxoSmithKline Nearly $500 Million in Bribery Case http://t.co/bEO2kFxH8x $GSK +3930% mentioned in News, Blogs & Tweets
Stoxline Investing
19 Sep 14 18:24:00
Top Buy Stocks for Sept.22: $AXP, $BEE, $CVX, $GSK, $HPQ, $MSFT, $XRX http://t.co/yAXirB1h5d
				
				
  +Follow August 16, 2013 9:54AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.